SEHK:867Pharmaceuticals
China Medical System (SEHK:867) Stock Revenue Push Meets Persistent Earnings Strain
China Medical System Holdings went into these half year numbers with a stock that has cooled in the short term, down around 2.6% over the past week and 3.5% over the month, despite a positive 3 month run. The market reaction into the release hinted at caution, yet the headline result is firm. First half 2026 revenue came in at ¥4,500.7m and net income excluding extra items was ¥986.1m. Basic earnings per share of ¥0.4075 in this specialty pharma group now sits against a trailing P/E of 15.9x,...